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Abstract 
This paper examines our current understanding of the phenomena of emergence delirium, 
which can occur following general anesthesia.  Much research has been conducted to 
elucidate the causative factors of this condition, with findings ranging from anxiety to 
volatile agents and the neurodevelopment of the brain (Aono, Ueda,  & Mamiya, 1997; 
Kain et al., 2004; McLott, Jurecic, Hemphill, & Dunn, 2013).  While much of our 
understanding of emergence delirium has come from studying children, who are more 
prone to this condition, we can attempt to learn even more by examining the increased 
incidence of emergence delirium that occurs in those with post-traumatic stress disorder 
or PTSD (Lovestrand, Phipps, & Lovestrand, 2013).  Not only has our understanding of 
brain structure and function increased in recent years, but our improved ability to target 
specific receptors with pharmacological agents has also enabled us to discover ways to 
lessen the incidence of this upsetting and potentially dangerous response to general 
anesthesia (Dahmani et al., 2010).  Current treatments that target GABA, opioid and 
alpha-2 receptors appear to demonstrate the greatest effect, however, there is wide 
variability within these receptor classes and various side effects that must also be 
considered.  Individual genetic variations in receptor subtypes only complicates the 
picture, and may be the focus of future research as our understanding of and attention to 
the human genome increases. 
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                  Understanding and Treating Emergence Delirium 
Emergence delirium, also referred to as emergence agitation and emergence 
excitement, is a condition that can occur following the administration of general 
anesthesia.  This condition was first described by Dr. Eckenhoff in the 1960s, who 
referred to it as post anesthetic excitement and considered it a dissociated state of 
consciousness (Mohkamkar et al., 2014).  Emergence delirium can be defined as a state 
of mental confusion, agitation and disinhibition marked by hyperexcitability, crying, 
restlessness and hallucinations during emergence from general anesthesia (Stamper, 
Hawks, Taicher, Bonta, & Brandon, 2014).  During this period, attempts to reorient the 
patient through verbal and other means are ineffective.  Although emergence delirium is 
most likely to occur during the first 30 minutes following anesthesia and tends to last for 
between 15 and 30 minutes, it has been reported to occur as long as 45 minutes following 
emergence and to last for upwards of two days in the most extreme cases (Dahmani, 
Delivet, & Hilly, 2004; Munk, Anderson, & Gogenur, 2013).  Emergence delirium 
appears to effect children more often than adults, with studies showing that it occurs at 
rates of three to eight times greater in children (Stamper et al., 2014).   
                                              Literature Review 
Emergence delirium causes a great deal of stress for anesthesia and nursing 
personnel, as well as for the patient and the patient’s family.  Not only is there increased 
psychological stress as a result of the patient’s condition; the agitation, flailing arms, and 
inability to reason with and control the patient places them at great risk for injury 
(Lepouse, Lautner, Liu, Gomis, & Leon, 2006; Sikich & Lerman, 2004).  During this 
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period there is increased risk of physical harm from pulling out IV lines and drains, as 
well as the risk of self-extubation and other bodily injury (Wofford & Vacciano, 2011).  
In addition, the demands placed upon staff are greatly increased, as nearly 50% of those 
who develop emergence delirium require extra PACU personnel to take care of them 
(Hudek, 2009).   
When emergence delirium was first recognized in the 1960s, it was thought to be 
due primarily to the effects of postoperative pain and the resulting discomfort and 
agitation that ensued.  During this time period the primary anesthetic agents being used 
were ether and cyclopropane, which were both felt to contribute strongly to emergence 
excitement (Eckenhoff, Kneale, & Dripps, 1961).  Although no specific studies 
comparing the incidence of emergence delirium from one anesthetic agent to another 
were conducted during this time, it does not appear that anesthetists felt there was a 
greater propensity for delirium or agitation with any specific agent over another.  In 
subsequent decades, when halothane was the primary anesthetic agent in use, discussion 
of emergence delirium went by the wayside; this was presumably due to a decreased 
incidence of such effects with the use of halothane.  It was not until the advent of more 
volatile modern agents such as sevoflurane and desflurane that discussion of emergence 
delirium once again made its way back into the literature.   
Despite more than four decades of exploration on emergence delirium in the 
literature, researchers still do not have a full grasp of the exact cause of this condition.  
Although various factors appear to place an individual at greater risk for developing this 
condition, no single factor has emerged as the primary cause.  One of the reasons it has 
been so difficult to determine the exact causative factors of emergence delirium is that 
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there has not been a consistent grading scale for the verification of emergence delirium in 
postoperative patients (Munk, Andersen, & Gogenur, 2013).  In fact, more than fifteen 
measurement tools have been used over the years to define and grade emergence 
delirium, and few of these tools have been able to effectively differentiate between pain 
and agitation or delirium, as they present with many similar characteristics (Nasr & 
Hannallah, 2011).   
Of the measurement tools used, the most frequently chosen are the Watcha scale, 
the Cravero scale and the more recently created Pediatric Anesthesia Emergence 
Delirium (PAED) scale.  Each of these scales has been designed primarily to examine 
emergence delirium in the pediatric population.  Both the Watcha and Cravero scales are 
similar and relatively easy to use as they rank order a child’s behavior from asleep or 
obtunded to wild and thrashing (Reduque & Verghese, 2013).  The concern with these 
two scales is that they both involve the rating of behaviors that are not necessarily 
specific to emergence delirium, but could simply be a reflection of untreated pain (Sikich 
& Lerman, 2004).  The PAED scale was developed in an attempt to address this and 
examines disturbances in consciousness, such as reduced awareness of the environment 
and an inability to focus or shift attention, rather than simply a child’s degree of physical 
restlessness (Sikich & Lerman, 2004).  In order to rate these more subtle disturbances, the 
PAED scale requires the practitioner to evaluate eye contact and whether the child makes 
purposeful movements.  The degree to which each behavior is demonstrated is further 
rank-ordered, making the PAED scale a much more time consuming and cumbersome 
measurement tool than the others, and limiting its utility in clinical assessment.  Another 
issue further hampering the routine use of the PAED scale is that the developers of this 
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scale never defined the numeric value for which a diagnosis of emergence delirium 
would be attributable.  Consequently, various studies have been conducted to compare 
the results of the most frequently used scales to the more recently created PAED scale, 
and a consensus has begun to develop that defines emergence delirium as being 
consistent with a PAED scale rating of greater than 10 to 12 (Bajwa, Costi, & Cyna, 
2010; Nasr & Hannallah, 2011).   
Over the years the study of emergence delirium has been primarily focused on 
pediatric anesthesia as it has been observed to be a condition more common to this 
population.  Consequently, there has been a paucity of studies examining this 
phenomenon as it occurs in the overall surgical population (Wilson, 2014).  Due to the 
wide range in scoring criteria used over the years the incidence of emergence delirium in 
the pediatric population has been considered to be as low as 20% by some reckonings and 
as high as 80% according to others (Rahimzadeh, Faiz, Alebouyeh Dasian, & Sayarifard, 
2014), although most studies put the figure at closer to the 20% mark (Bong & Ng, 
2009).  More recently, emergence delirium has gained additional attention outside the 
realm of pediatric anesthesia as there has been increased attention placed upon 
posttraumatic stress disorder (PTSD) in the adult population.  The primary cause of this 
increased attention has come from the rise in the incidence of PTSD in the military 
population, as a result of the prolonged conflicts in Afghanistan and Iraq.  It is quite 
possible that the renewed attention placed upon this phenomenon will help us not only 
better understand and treat this condition, but more importantly, prevent its occurrence in 
the first place. 
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There are a number of factors that appear to bear a strong correlation with the 
development of emergence delirium.  These precipitating factors include age (younger 
patients between the ages of 2 and 6, as well as those over 65), increased levels of 
preoperative anxiety, postoperative pain, short surgical duration, use of sevoflurane, 
surgery involving the head and neck, and rapid emergence from anesthesia (Aono, Ueda, 
& Mamiya, 1997; Kain et al., 2004; Lepouse et al., 2006; Nasr & Hannallah, 2011; 
Radtke et al, 2010; Stamper et al., 2014; Yu, Chai, Sun, & Yao, 2010).  Although 
emergence delirium is possible following total intravenous anesthesia, it has been found 
to be nearly four times more common when inhalation anesthetics are used (Yu et al., 
2010).  In addition, the common perception that individuals who experience a rough 
induction of anesthesia often experience a rough emergence may not simply be an 
anecdotal finding, as Mohkamkar et al. (2014) discovered when they found that 
individuals who were agitated during induction of anesthesia had a higher risk of 
developing emergence agitation.    
A number of explanations have been put forward in an attempt to explain why 
these various factors appear to be connected with an increased incidence of emergence 
delirium.  Eckenoff, Kneale and Dripps (1961) speculated that a sense of suffocation 
upon emergence from anesthesia was responsible for the frequent agitation seen 
following surgery on the neck and throat.  The increased incidence of emergence delirium 
following surgical procedures of short duration has been proposed to be due to a rapid 
washout of inhalation anesthetic agent before analgesic medication has had a chance to 
reach its peak effect (Mohkamkar et al., 2014).  The newer, more rapid acting volatile 
agents such as sevoflurane and desflurane have been speculated to cause emergence 
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delirium due to the fact that they result in a rapid emergence.  This last theory, however, 
was disproved by Vlajkovic and Sindjelic (2007), who found that even a step-wise 
decrease in sevoflurane - made in such a way as to slow emergence - did not appear to 
change the frequency of emergence delirium.  The fact that the rapid emergence from 
propofol anesthesia is not associated with emergence delirium further debunks this theory 
(Cohen, Finkel, & Hannallah, 2002). 
Although most studies seem to relate emergence delirium to sevoflurane 
anesthesia, studies of desflurane - and to a lesser extent isoflurane - have also consistently 
demonstrated a link to increased rates of emergence delirium (Vlajkovic & Sindjelic, 
2007).  Additionally, inadequate pain control is a rather hazardous predictive measure as 
well, due to the fact that so many of the criteria used to define emergence delirium, such 
as physical agitation, can also be caused by pain.  To further support the notion that pain 
is too simple a criterion upon which to base emergence delirium, is the fact that even 
painless procedures such as MRI have been found to result in emergence delirium 
(Bonhomme et al., 2012).  It appears that there is something in the nature of volatile 
agents that is responsible for the development of emergence delirium.  The fact that it 
occurs more often in children between the ages of 2 and 6, likely has to do with the 
underlying nature of neurodevelopment in children.  That increased levels of preoperative 
anxiety correlate strongly with the development of emergence delirium also suggests that 
there is a psychological component at work as well; perhaps it is some combination of 
these two factors that is ultimately responsible.   
A lot of research has been conducted examining the connection between 
preoperative anxiety and emergence delirium.  A study by Kain et al. (2004) found that 
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children with preoperative anxiety had a 12.5% increase in maladaptive behavioral 
changes following surgery, and that every ten point increase in a child’s anxiety score 
correlated with an approximately 10% increase in the rate of emergence delirium.  Not 
only do more anxious children tend to develop emergence delirium at nearly six times the 
frequency of less anxious children, but studies also indicate that more anxious children 
also report more pain during their hospital stay, as well as during their first three days at 
home (Kain et al., 2006).  Kain et al. (2004) also found that in addition to child-related 
factors influencing the rate of emergence delirium, the parents of anxious children are 
significantly more anxious in the holding area and upon separation from their child en 
route to the OR.  All of these findings underscore the importance of parental and child 
education within the perioperative setting to lessen procedural-related anxiety and thus 
emergence delirium.  To further support the case for effective preoperative preparation, it 
has been found that previous history of illness decreases the risk of emergence delirium 
in the adult population.  This is speculated to be due to the fact that these patients are 
more accustomed to the hospital environment and are therefore less anxious (Lepouse et 
al., 2006). 
When looking into emergence delirium and anesthesia in general, it does not take 
long before an examination of the mechanism of action of anesthetic agents and their 
effect on the central nervous system becomes a primary focus.  Interestingly, in the more 
than one hundred years that we have been using pharmacological agents to induce a state 
of anesthesia, we still cannot say with certainty just how these agents work upon the body 
to produce their desired effect.  While it was initially postulated that the effects of 
anesthetic agents were due to their lipid solubility and impact on the lipid bilayer of 
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neuronal membranes, it has since been proven that this basic explanation is not only too 
simplistic, but also incorrect (Bonhomme, Boveroux, Brichant, Laureys, & Boly, 2012).  
More modern hypotheses of the pharmacodynamics of volatile agents vacillate between 
the creation of a global inhibitory state and a more targeted, specific inhibition of various 
brain regions.   
The primary receptor responsible for inhibitory neurological impulses is the 
GABA receptor.  It is upon this receptor that agents such as benzodiazepines, alcohol and 
propofol have their effect; volatile agents are also believed to have some effect upon 
these receptors.  The chronic stress of PTSD has been found to result in neural 
remodeling of GABA receptors, with a consequent decrease in binding sites, which 
causes benzodiazepines to be less effective in reducing hyperarousal (Geuze, van 
Berckel, & Lammertsma, 2008).  Researchers speculate that the same reduction in 
benzodiazepine binding sites may occur with respect to the binding sites for volatile 
anesthetics, and that this may play a role in the increased agitation that can occur 
following general anesthesia with these agents.  They further speculate that the effect of 
chronic stress from PTSD on GABA receptors may be somehow similar to the stress of 
general anxiety, which may be the reason for the increases in emergence agitation 
exhibited by more anxious individuals. 
Several studies have demonstrated that the amygdala is an important area for the 
inhibitory effects of anesthetic agents.  In a review of relevant literature by McLott, 
Jurecic, Hemphill, and Dunn (2013), the authors showed that GABA receptors exist in 
large quantities within the amygdalocentic neurocircuitry, that area of the brain 
comprising the amygdala and its connections to the medial prefrontal cortex and the 
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hippocampus.  It is these areas of the brain that are responsible for the amnestic effects of 
general anesthetics (Alkire & Nathan, 2005).  Interestingly, the stress response has been 
intricately linked to the amygdala as well, as it is this area of the brain that is associated 
with the transmission of fear and excitation to the hypothalamus (McLott, Jurecic, 
Hemphill, & Dunn, 2013).   
Further underscoring the link between emergence delirium and activity within the 
amygdala, studies have shown that auditory stimulation activates that part of the 
amygdala responsible for fear conditioning.  Researchers have also found that chronic 
stress causes a down-regulation of Ca+-activated potassium channels, which results in 
increased activity within the amygdala in response to auditory stimuli (Guo et al., 2012).  
As hearing is the first sense to return during emergence from general anesthesia, it 
follows that an exaggerated fear response to auditory stimuli may be a potential trigger 
for emergence delirium.  The connection between auditory stimulation and increased 
activity within the amygdala has been demonstrated to such an extent that in some 
institutions the primary method used to gain the attention of a patient during emergence is 
to rub their feet rather than to use verbal commands (Kain et al., 2006).  Interestingly, 
hyperactivity of the amygdala has also been connected to increased levels of 
impulsiveness, aggression and violence in response to provocative stimuli in the general 
human population (Siever, 2008).  It has further been shown that a patient’s level of 
impulsivity correlates strongly with increases in emergence delirium (Mountain et al., 
2011).  Hyperactivity of the amygdala is more likely to lead to this type of behavior, 
particularly when there is diminished cortical regulation as occurs during a state of 
anesthesia.  As the cerebral cortex is primarily responsible for regulation and inhibition of 
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lesser order brain functions, it is logical to conclude that any inhibition of a fear response 
will not take place until these higher order functional areas of the central nervous system 
have recovered from the effects of general anesthesia (Dahmani, Delvit, & Hilly, 2014). 
Another area postulated to be involved in emergence delirium is the locus 
coeruleus.  This is an area within the pons of the brainstem that is involved in the 
physiologic response to stress.  The locus coeruleus sends excitatory signals to various 
target areas within the central nervous system by way of the neurotransmitter 
norepinephrine, and as such it plays a role in controlling the overall activity level of the 
brain (Miller, 2011).  Lending credence to this area being important to our understanding 
of emergence delirium is the finding by Yasui, Masaki, and Kato (2007), who showed 
that blocking norepinephrine release within the locus coeruleus, by the administration of 
the alpha-2 agonist dexmedetomidine, was useful in preventing emergence delirium.  
Furthermore, these researchers found that the order of inhalation anesthetics in activating 
excitatory changes within the locus coeruleus is in accord with the rate at which each 
inhalation agent appears to be implicated in causing emergence delirium.  
Since the brain does not fully develop until well into the late teenage years, there 
are significant physiological differences between the brains of children and adults, and 
these differences clearly play a role in the increased incidence of emergence delirium 
among pediatric patients.  Interestingly, similarities have been found between the 
electroencephalogram (EEG) patterns seen during emergence delirium and those that 
occur during night terrors in children (Dahmani, Delivet, & Hilly, 2014).  Sevoflurane, as 
well as desflurane and isoflurane, all induce EEG changes that are similar to one another 
and markedly different from those produced by halothane, an agent associated with a 
UNDERSTANDING AND TREATING EMERGENCE DELIRIUM 13 
much lower incidence of emergence delirium.  This suggests that some degree of 
interference in the balance between synaptic inhibition and excitement may be at play 
(Vlajkovic & Sindjelic, 2007). 
Due to the finding that adults with PTSD have rates of emergence delirium 
roughly equal to those exhibited by children - nearly 29% in a study done by Wilson 
(2013) - it makes sense to examine the effect of pharmacological agents used in the 
treatment of PTSD on the incidence of emergence delirium.  One of the more commonly 
prescribed classes of drugs for the treatment of PTSD are SSRIs, or selective serotonin 
reuptake inhibitors.  These drugs have been shown to dramatically decrease the incidence 
of emergence delirium, suggesting involvement of serotononergic processes in the 
etiology of both PTSD and emergence delirium (Lankinen, Avela, & Tarkkila, 2006).  
Serotonin has been found to enhance cortical function in areas known to modulate and 
suppress aggressive behaviors, and SSRIs have been found to reduce impulsive 
aggression and decrease noradrenergic activity (Siever, 2008).  The primary limiting 
factor for the use of these agents in the general surgical population is that they tend to 
take upwards of six weeks to take effect (Lovestrand, Phipps, & Lovestrand, 2013).  The 
fact that sevoflurane and other inhalation anesthetics often lead to emergence delirium 
may be due in large part to the finding that in low doses these agents exhibit a degree of 
EEG activation, followed at higher doses by EEG suppression (Bennett et al., 2009).  
Thus, when volatile agent concentrations are low, as occurs during emergence, there is 
actually an increase in brain activity.  The fact that only certain individuals experience 
emergence delirium may be due in part to the finding that there is both genetic variation, 
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as well as age-based variation in the makeup of the different subtypes of GABA receptors 
(Kim, 2011). 
Of course no study of the phenomena of emergence delirium would be complete 
without addressing the means by which anesthetists can attempt to decrease the incidence 
of this adverse response to anesthesia.  Numerous studies have investigated the effect that 
agents such as opioids and benzodiazapines have upon the development of emergence 
delirium.  It makes sense that researchers would have examined these agents, as both pain 
and anxiety have been strongly implicated in the development of emergence delirium.  
While studies have been mixed with regards to the effect of benzodiazepines - 
specifically midazolam - studies examining the effect of opioids have demonstrated very 
strong results.  Interestingly, while midazolam has had mixed results in terms of its effect 
on emergence delirium, with a recent meta-analysis by Dahmani et al. (2010) 
demonstrating that it is not effective in preventing emergence delirium, it has been shown 
to consistently reduce preoperative anxiety.  While it may seem surprising, then, that 
midazolam has not been found to be effective in decreasing the incidence of emergence 
delirium there are several factors that may help to explain this finding.  First of all, 
providers generally are more apt to give midazolam preoperatively to individuals with 
increased levels of anxiety, the very individuals who have been found to have the greatest 
risk of developing agitation in the first place.  Despite the strong link between 
preoperative anxiety and emergence delirium, the lack of an effect from preoperative 
midazolam may be due to the fact that it often does not last through to the recovery 
period (Mountain, Smithson, Cramolini, Wyatt, & Newman, 2011).  In addition, 
midazolam has been found to produce paradoxical effects of anxiety and agitation in 
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certain individuals and benzodiazapines have also been shown to decrease the pain 
threshold, and thus may result in pain that is not adequately controlled by a standard dose 
of narcotic.  It may be this pain that individuals are responding to, as pain itself has been 
linked to increased rates of emergence delirium. 
When a patient does develop emergence delirium, treatment typically consists of 
giving fentanyl, or in some institutions dexmedetomidine.  In a study by Stamper et al. 
(2014) the use of these medications was found to effectively treat emergence delirium in 
over 60% of individuals.  Fortunately for those individuals for whom treatment was not 
effective, emergence delirium is a self-limiting phenomena, generally resolving within 15 
to 30 minutes.  Interestingly, one of the most effective treatments appears to be parental 
presence during recovery from anesthesia and may even work faster than 
pharmacological agents (Arai et al., 2007; Vlajkovic & Sindjelic, 2007). 
When one considers the typical physiological factors that come into play during 
surgery, one of the first things to be considered is the effect of stimulation upon the 
sympathetic nervous system.  This is the system responsible for the fight or flight 
phenomena that is commonly discussed in regards to the stress response.  In this stress 
response the body releases catecholamines, primarily norepinephrine, which travels to 
target tissues to activate specific adrenergic receptors.  In the peripheral circulation the 
activation of these receptors results in vasoconstriction and other target organ directed 
effects, while in the central nervous system the effect is to increase alertness and create a 
state of hypervigilance.  It would seem reasonable, therefore, to predict that blocking the 
effect of norepinephrine within the central nervous system may be an effective means of 
inducing a quieting or suppressing of arousal and consciousness.  A couple of 
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medications that work in this function have gained a great deal of attention in terms of 
their effects on diminishing the frequency of emergence delirium.  These drugs are the 
alpha-2 receptor agonists, clonidine and dexmedetomidine.  As alpha-2 agonists they 
cause a negative feedback inhibition of alpha-1 receptors, the same receptors primarily 
stimulated by norepinephrine during periods of sympathetic stimulation.  Clonidine is 
frequently prescribed for its antihypertensive effect, however it has been found to have 
sedating and analgesic properties by virtue of its central nervous system effects as well 
(Kulka, Bressem, & Tryba, 2001).  A study by Tazeroualti, De Groote and De Hert, 
(2007), found that oral clonidine administered prior to the induction of general anesthesia 
resulted in a significant decrease in the incidence of emergence delirium, while a study 
by Bock, Kunz and Schreckenberger (2002) showed that intraoperative administration of 
clonidine reduced emergence delirium to just 5%, with no delay in discharge as can occur 
when more sedating medication is given.   
A more novel anesthetic agent, dexmedetomidine, has eight times the affinity of 
clonidine for the alpha-2 receptor (Guler et al., 2005) and has received a great deal of 
attention in the prevention of emergence delirium.  While dexmedetomidine is most 
frequently given by infusion, a study by Ibache, Munoz, Brandes, and Morales (2004) 
found that a bolus administration of 0.3 mcg/kg at the end of anesthesia reduced the 
incidence of emergence delirium from 47% to just 5%.  In addition, dexmedetomidine 
has an advantage in that it has been shown to decrease the frequency of airway problems 
resulting from laryngeal stimulation during extubation (Gulen et al., 2005; Shukry et al., 
2005).  Another study by Guler et al. (2005) showed that a bolus administration of 
dexmedetomidine as high as 0.5 mcg/kg was similarly effective, and even at this higher 
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dose did not result in either hypotension or bradycardia, two of the most common adverse 
effects of this medication.  Although not FDA approved for oral use, a study by Zub, 
Berkenbosch and Tobias (2005) showed that oral doses of 3 mcg/kg of dexmedetomidine 
given preoperatively were effective in reducing emergence delirium and there were no 
complaints about palatability or bitter taste as is the case with oral midazolam.  The main 
disadvantage of dexmedetomidine is that it remains quite expensive.  For this reason the 
much less costly alpha-2 agonist, clonidine, may be the most practical agent to use to 
blunt the noradrenergic response of centrally mediated sympathetic stimulation and 
resultant emergence delirium.   
The intravenous induction agent propofol has been studied extensively for its 
ability to decrease emergence delirium in both children and adults.  A study by Abu-
Shahwan (2007) showed that doses of propofol of 1 mg/kg just prior to emergence from 
general anesthesia dramatically reduced the incidence of emergence delirium and was not 
shown to delay recovery or discharge time.  Unlike the effect with dexmedetomidine, the 
effect of propofol appears to be time sensitive, as only doses given just prior to 
emergence or by continuous infusion (as in total IV anesthesia) are effective (Uenzono, 
Goto & Terui, 2000).  When propofol is given earlier in a case, it has no effect on the 
incidence of emergence delirium (Cohen, Finkel & Hannalllah, 2002).  Another potential 
agent for the reduction of emergence delirium is lidocaine.  In a study by Elgebaly (2013) 
it was shown that preoperative lidocaine injected into the sub-tenon space for ocular 
surgery not only reduced airway reflexes and the risk of laryngospasm, but also reduced 
the incidence of emergence agitation, with no increase in sedation in the recovery room.  
Rahimzadeh et al. (2014) also examined the effectiveness of lidocaine, but in this case IV 
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lidocaine was used following mask induction of general anesthesia with sevoflurane.  
They found a significant decrease in emergence agitation with the use of this medication 
and an even greater decrease when it was used in combination with propofol.  These 
results led researchers to speculate that lidocaine is effective by way of its ability to 
diminish the sympathetic response to intubation and noxious stimuli, thereby decreasing 
activation of the sympathetic nervous system.   
Fentanyl has been shown to reduce the incidence of emergence delirium as well, 
with a recommended dose to achieve this effect of 2.5 mcg/kg intravenously (Ford, 
2013).  However, other studies have shown that 1 mcg/kg IV given ten minutes prior to 
the end of surgery is adequate, and will lessen the chances of any adverse side effects 
(Vlajikov & Sindjelic, 2007).  One might speculate that fentanyl’s effect is simply due to 
its analgesic properties, as emergence delirium has long been associated with increases in 
post-operative pain.  However, in studies of pediatric patients undergoing objectively 
non-painful MRI studies, the use of fentanyl dramatically reduced the frequency of 
emergence delirium (Bonhomme et al., 2012).  One of the major disadvantages of 
fentanyl over propofol is the increased incidence of nausea and vomiting that occurs with 
a narcotic-based approach.  A study by Kim, Moon, Kim and Lee (2012) found a 26% 
incidence of PONV when fentanyl was used, as compared to just 6% with the use of 
propofol. 
While practitioners may be concerned about the risk of increased respiratory 
depression and prolonged recovery from anesthesia when adjunct medications such as 
propofol and fentanyl are used, these concerns do not appear to justify any routine 
withholding of such medications for the prevention of emergence delirium during post 
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anesthesia recovery.  There are a variety of nonpharmacological methods that have 
proven to be effective in reducing the incidence of emergence delirium as well.  These 
consist of a quiet induction environment with decreased sensory stimuli, music therapy, 
and distraction by way of videos or touch screen games.  Interestingly, parental presence 
at induction has not been found to be consistently effective, although parental presence 
following emergence is (Dahmani, Delivet, & Hilly, 2014). 
Recent literature has devoted a great deal of coverage to concerns over 
postoperative cognitive dysfunction, although this is not a new phenomena and has been 
recognized for over a century (Woffard & Vacchiano, 2011).  Some have speculated that 
emergence delirium and postoperative cognitive dysfunction may be somehow linked, or 
that experiencing emergence delirium puts one at increased risk for postoperative 
cognitive dysfunction.  While both syndromes can be characterized primarily by the 
presence and severity of apparent confusion and agitation, emergence delirium is 
transient and has not been linked to any increase in mortality, whereas postoperative 
cognitive dysfunction is associated with both increases in mortality and can remain quite 
pervasive in some individuals years after the provoking surgery (Woffard & Vacciano, 
2011).  Although emergence delirium is transient, it has been found to be associated with 
postoperative maladaptive behavioral changes, with children who display emergence 
delirium being seven times more likely to develop postoperative maladaptive behaviors 
such as night terrors, bed wetting, general anxiety and loss of appetite for up to 2 weeks 
following surgery (Kain et al., 2004, Kain et al., 2006).  Of note, it has been found that 
children given preoperative midazolam and therefore had lower preoperative anxiety 
levels had fewer maladaptive behavioral changes following anesthesia even though the 
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incidence of emergence delirium was unchanged (Kain, Mayes, Caramico, Wang, & 
Hofstadter, 1999).   
Discussion 
  There has been much progress made in our understanding of emergence 
delirium since it was first described in the early 1960s.  Not only has there been a vast 
increase in our knowledge of human physiology and pharmacology, but there has also 
been an explosion of attention paid to all manner of medical conditions.  Anesthesia 
providers now have a wide range of pharmacological agents that can be used to help 
attenuate reactions to anesthesia such as emergence delirium, and new agents are 
continually being investigated.  Although an understanding of the precise mechanism 
behind emergence delirium continues to elude us, our improved mapping of the human 
brain at the neuronal and receptor levels has led to a much better understanding of the 
functions various brain regions play in both arousal and aggression.  As further progress 
is made in neuroscience we will continue to gain a deeper understanding of complex 
phenomena such as emergence delirium, and consequently we may be able to target 
treatment to fully prevent this disturbing and potentially dangerous condition.    
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